Moelis cut to Sell at UBS on overly optimistic expectations
UBS analyst Michael Brown downgraded Moelis to Sell from Neutral with a price target of $60, up from $58. The firm contends that the stock's risk-reward is increasingly skewed to the downside as consensus expectations for a sharp acceleration in advisory revenues and earnings appear to be too optimistic, creating risk